Guanazodine: Difference between revisions

Browse history interactively

← Previous edit

Content deleted Content added

VisualWikitext

@@ Line 1: / Line 1: @@
+{{Short description|Chemical compound}}
-{{drugbox
+{{Drugbox
-| Verifiedfields = changed
+| verifiedrevid = 443212982
-| UNII_Ref = {{fdacite|changed|FDA}}
+| IUPAC_name = 2-(Azocan-2-ylmethyl)guanidine
-| UNII = 7N05KQ38YI
+| image = Guanazodine.png
-| verifiedrevid = 407386406
+| alt = Skeletal formula of guanazodine
-| IUPAC_name        = 2-(Azocan-2-ylmethyl)guanidine
+| image2 = Guanazodine 3D ball.png
-| image             = Guanazodine.png
+| alt2 = Ball-and-stick model of the guanazodine molecule
-| CAS_number        = 32059-15-7
-| ATC_prefix        = C02
+<!--Clinical data-->
-| ATC_suffix        = CC06
+| tradename =
-| PubChem           = 36054
+| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
+| pregnancy_US = <!-- A / B            / C / D / X -->
+| pregnancy_category =
+| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
+| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
+| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
+| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
+| legal_status =
+| routes_of_administration =
+<!--Pharmacokinetic data-->
+| bioavailability =
+| protein_bound =
+| metabolism =
+| elimination_half-life =
+| excretion =
+<!--Identifiers-->
+| CAS_number = 32059-15-7
+| ATC_prefix = C02
+| ATC_suffix = CC06
+| PubChem = 36054
+| ChEMBL = 2008565
 | DrugBank_Ref = {{drugbankcite|correct|drugbank}}
-| DrugBank          =
+| DrugBank =
+| UNII_Ref = {{fdacite|correct|FDA}}
+| UNII = 7N05KQ38YI
 | KEGG_Ref = {{keggcite|correct|kegg}}
 | KEGG = D07169
+| ChemSpiderID      = 33166
-| C=9|H=20|N=4
-| molecular_weight  = 184.28 g/mol
+<!--Chemical data-->
-| bioavailability   =
-| protein_bound     =
+| C=9 | H=20 | N=4
-| metabolism        =
+| smiles            = C1CCCNC(CC1)CNC(=N)N
+| StdInChI          = 1S/C9H20N4/c10-9(11)13-7-8-5-3-1-2-4-6-12-8/h8,12H,1-7H2,(H4,10,11,13)
-| elimination_half-life =
-| excretion         =
+| StdInChIKey       = ZCVAIGPGEINFCX-UHFFFAOYSA-N
-| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
-| pregnancy_US      =  <!-- A / B            / C / D / X -->
-| pregnancy_category=
-| legal_AU =  <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
-| legal_CA =  <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
-| legal_UK =  <!-- GSL, P, POM, CD, or Class A, B, C -->
-| legal_US =  <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
-| legal_status      =
-| routes_of_administration =
 }}
+'''Guanazodine''' is an [[Antihypertensive drug|anti-hypertensive]] [[sympatholytic]] drug. <ref name="pmid1035187">{{cite journal | vauthors = Shimizu T, Hamakawa H, Tozuka T, Ono H | title = [Pharmacological effects of [(octahydro-2-azocinyl)methyl] guanidine(guanazodine): its action mechanism and hypotensive effect] | language = Japanese | journal = Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica | volume = 72 | issue = 7 | pages = 837–50 | date = October 1976 | pmid = 1035187 | doi = 10.1254/fpj.72.837 | url = | doi-access = free }}</ref><ref>{{Cite web |title=Drugbank Online - Guanazodine |url=https://go.drugbank.com/drugs/DB13604}}</ref><ref>{{Cite web |title=National Center for Advancing Translational Sciences |url=https://drugs.ncats.io/drug/7N05KQ38YI}}</ref>
-'''Guanazodine''' is a [[sympatholytic]] drug.
+==References==
+{{Reflist}}
 {{Antihypertensives and diuretics}}
-[[Category:Guanidines]]
+[[Category:Adrenergic release inhibitors]]
 [[Category:Azocanes]]
+[[Category:Guanidines]]